title: Altered growth hormone (GH) secretion in women gaining weight during hormone replacement therapy (HRT).
abstract: OBJECTIVE
  The relationship between GH response to GHRH-stimulation and changes in body weight in pre- and postmenopausal women before as well as after 4 and 20-22 weeks of oral HRT was tested.
  
  
  METHODS
  18 postmenopausal women (FSH > 30 mU/ml) were compared to 18 premenopausal women suffering from post-pill amenorrhoea (FSH < 10 mU/ml). Both patient-groups reported an anamnestic increase in body weight during former use of sex hormones. In addition 18 postmenopausal women without anamnestic weight change were studied.
  
  
  RESULTS
  A significant reduction in GH response to GHRH stimulation was observed during the first month of HRT in both groups gaining weight. However, the body mass index of the patients reverted to pretherapeutic levels after 5 months of HRT. In all patients, a small but statistically significant increase in IGF-1 levels was registered during HRT. These changes in GH stimulation testing and IGF-1 levels were accompanied by distinct changes in body weight. No alterations in GHRH response were observed in those patients whose body weight did not increase.
  
  
  CONCLUSIONS
  Our results confirm that in predisposed women, HRT is associated with increments in body weight as well as with changes in the GH-IGF-1 axis.
authors.affiliation: University of Vienna Medical School, Department of Gynecology and Obstetrics, Austria.
authors.forename: B W
authors.initials: BW
authors.lastname: Hartmann
authors.forename: S
authors.initials: S
authors.lastname: Kirchengast
authors.forename: A E
authors.initials: AE
authors.lastname: Albrecht
authors.forename: G
authors.initials: G
authors.lastname: Söregi
authors.forename: J C
authors.initials: JC
authors.lastname: Huber
mesh_terms: D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects*; D015914:Estrogen Replacement Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005500:Follow-Up Studies; D013007:Growth Hormone-Releasing Hormone; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects; D012016:Reference Values
chemical_list: D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013007:Growth Hormone-Releasing Hormone